Influenza virus vaccination in kidney transplant recipients: Serum antibody response to different immunosuppressive drugs

Clinical Transplantation

Volumn 24, Issue 1, 2010, Pages

  Salles, Mauro J C ^a   Sens, Yvoty A S ^b   Boas, Lucy S V ^c   Machado, Clarisse M ^c  

^a Santa Casa de Sao Paulo School of Medicine   (Brazil)

^b Nephrology Division   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antibody response; Immunosuppressive drugs; Influenza; Kidney transplantation; Vaccination

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; INFLUENZA VACCINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; AGED; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG HYPERSENSITIVITY; ERYTHEMA; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; KIDNEY TRANSPLANTATION; LIVER GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTECTION; RESPIRATORY TRACT DISEASE; SEROCONVERSION; SWELLING; SYSTEMIC DISEASE; VIRUS STRAIN;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; AZATHIOPRINE; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; VACCINES, INACTIVATED; YOUNG ADULT;

EID: 74949084982     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.01095.x     Document Type: Article

References (28)

1. Vilchez RA, Fung J, Kusne S. The pathogenesis and management of influenza virus infection in organ transplant recipients [Review]. Transpl Infect Dis 2002, 4:177.
2. Ison MG. Respiratory viral infections in transplant recipients. Curr Opin Organ Transplant 2005, 10:312.
3. Burroughs M, Moscona A. Immunization of pediatric solid organ transplant candidates and recipients [Review]. Clin Infect Dis 2000, 30:857.
4. Cavdar C, Sayan M, Sifil A. The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients. Scand J Urol Nephrol 2003, 37:71.
5. Ljungman P, Andersson J, Aschan J. Influenza A in immunocompromised patients. Clin Infect Dis 1993, 17:244.
6. Alpalsch AM, Green M, Ledesma-Medina J, Nour B, Wald ER. Parainfluenza and influenza virus infections in pediatric organ transplant recipients. Clin Infect Dis 1995, 20:394.
7. Malavaud S, Malavaud B, Sandres K. Nosocomial outbreak of influenza virus A (H3N2) infection in solid organ transplant department. Transplantation 2001, 72:535.
8. Vilchez RA, McCurry K, Dauber J. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2002, 2:287.
9. Singh N. Infectious complications in organ transplant recipients with the use of calcineurin-inhibitor agent-based immunosuppressive regimens [Review]. Curr Opin Infect Dis 2005, 18:342.
10. Batiuk TD, Bodziak KA, Goldman M. Infectious diseases prophylaxis in renal transplant patients: a survey of US transplant centers. Clin Transplant 2002, 16:1.
11. Machado CM, Cardoso MR, da Rocha IF, Boas LS, Dulley FL, Pannuti CS. The benefit of influenza vaccination after bone marrow transplantation. Bone Marrow Transplant 2005, 36:897.
12. Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 2004, 4(Suppl 10):105.
13. Blumberg EA, Albano C, Pruett T. The immunogenicity of influenza virus vaccine in solid organ transplant recipients. Clin Infect Dis 1996, 22:295.
14. Smith KGC, Isbel NM, Catton MG, Leydon JA, Becker GJ, Walker RG. Suppression of the humoral immune response by mycophenolate mofetil. Nephrol Dial Transplant 1998, 13:160.
15. Sanchez-Fructuoso AI, Prats D, Naranjo P. Influenza virus immunization effectively in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols: mycophenolate versus azathioprine. Transplantation 2000, 69:436.
16. Scharpé J, Evenepoel P, Maes B. Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant 2008, 8:332.
17. Beyer WE, Palache AM, Luchters G, Nauta J, Osterhaus ADME. Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination. Virus Res 2004, 103:125.
18. Mack DR, Chartrand SA, Ruby EI, Antonson DL, Shaw BW, Heffron TG. Influenza vaccination following liver transplantation in children. Liver Transpl Surg 1996, 2:431.
19. Zei T, Neri M, Iorio AM. Immunogenicity of trivalent subunit and split influenza vaccine (1989-90 winter season) in volunteers of different groups of age. Vaccine 1991, 9:613.
20. Goronzy JJ, Fulbright JW, Crowson CS, Poland GA, O'Fallon WM, Wyand CM. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol 2001, 75:12182.
21. Blaine WB, Luby JP, Martin SM. Severe illness with influenza B. Am J Med 1980, 68:181.
22. Stiver HG, Graves P, Mieklejohn G, Schroter G, Eickhoff TC. Impaired serum antibody response to inactivated influenza A and B vaccine in renal transplant recipients. Infect Immun 1977, 16:738.
23. Duchini A, Goss JA, Karpen S, Pockros PJ. Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols [Review]. Clin Microbiol Rev 2003, 16:357.
24. Ballet C, Roussey-Kesler G, Aubin JT. Humoral and cellular responses to influenza vaccination in human recipients naturally tolerant to a kidney allograft. Am J Transplant 2006, 6:2796.
25. Willcocks LC, Chaudhry AN, Smith JC. The effects of sirolimus therapy on vaccine responses in transplant recipients. Am J Transplant 2007, 7:2006.
26. Rentenaar RJ, van Diepen FN, Meijer RT. Immune responsiveness in renal transplant recipients: mycophenolate acid severely depresses humoral immunity in vivo. Kidney Int 2002, 62:319.
27. Lindemann M, Witzke O, Lutkes P. ELISpot assay as a sensitive tool to detect cellular immunity following influenza vaccination in kidney transplant recipients. Clin Immunol. 2006, 120:342.
28. Skowronski DM, De Serres G, Scheifele D. Randomized, double-blind, placebo-controlled trial to assess the rate of recurrence of oculorespiratory syndrome following influenza vaccination among persons previously affected. Clin Infect Dis 2003, 37:1059.